Amethyst Radiotherapy Group, a leading provider of non-surgical oncology treatment in Europe, has successfully raised a significant $300,000,000 in funding. The company's mission revolves around helping cancer patients in their fight against the disease, with 15 clinics spread across 6 countries. Amethyst Radiotherapy treats approximately 29,000 patients every year, offering top-quality care through a combination of expert medical professionals, state-of-the-art techniques, and cutting-edge equipment. This latest funding round will further strengthen their ability to provide unparalleled treatment and support to those battling cancer, reinforcing their commitment to delivering exceptional care and outcomes for their patients.










.png&w=3840&q=75)


